Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash from Investing Activities (2020 - 2026)

PROCEPT BioRobotics has reported Cash from Investing Activities over the past 7 years, most recently at -$2.9 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 58.71% to -$2.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$10.4 million through Mar 2026, down 142.71% year-over-year, with the annual reading at -$9.4 million for FY2025, 112.2% down from the prior year.
  • Cash from Investing Activities was -$2.9 million for Q1 2026 at PROCEPT BioRobotics, down from -$1.8 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$55000.0 in Q1 2022 and troughed at -$8.7 million in Q4 2023.
  • The 5-year median for Cash from Investing Activities is -$1.8 million (2025), against an average of -$2.6 million.
  • Year-over-year, Cash from Investing Activities crashed 9607.27% in 2023 and then skyrocketed 95.74% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$866000.0 in 2022, then crashed by 906.35% to -$8.7 million in 2023, then skyrocketed by 86.53% to -$1.2 million in 2024, then plummeted by 57.58% to -$1.8 million in 2025, then crashed by 57.51% to -$2.9 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Cash from Investing Activities are -$2.9 million (Q1 2026), -$1.8 million (Q4 2025), and -$2.9 million (Q3 2025).